-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Dentsply Sirona, Lowers Price Target to $13

Benzinga·11/16/2026 16:26:08
UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $17 to $13.